Search results

Order by most recent / most popular / relevance

Results: 1-10 of 254

US and European approaches to antibody patents

FB Rice
-
European Union, USA
-
June 13 2013

When monoclonal antibodies were first produced in 1974, Kohler and Milstein predicted that they “could be valuable for medical and industrial use”

Pharmaceutical trade marks case law round up for 2012early 2013

Corrs Chambers Westgarth
-
Australia, European Union, USA
-
June 6 2013

A brief wrap-up of recent decisions relating to trade marks in the pharma space from the EU, the United States and Australia

Interim measures awarded against European medicines agency

Bird & Bird
-
European Union
-
June 5 2013

Article 4(2) of EU Regulation 10492001, which governs freedom of information as to documents filed with EU agencies, requires that institutions such

Stem cell news - EPO revokes ‘Brüstle’ patent and new CJEU referral on the patentability of parthenotes

D Young & Co
-
European Union, Germany, United Kingdom
-
June 4 2013

As previously reported in this newsletter (1), the question of the patentability of technology based on the use of human embryonic stem cells (hESC

CJEU C-53511 marketing authorizations are not under certain conditions necessary for the repackaging of medicinal products

Roschier
-
European Union
-
May 20 2013

The Court of Justice of the European Union (CJEU) stated in its judgment dated 11 April 2013 that re-packaging medicinal products from an injection

UK: Court of Appeal refers questions on parallel imports to CJEU

Bird & Bird
-
European Union, United Kingdom
-
May 20 2013

The English Court of Appeal has considered the special derogation from the normal free movement of goods rules that formed part of the accession

EU Medicines Agency plans to appeal interim rulings on release of clinical trial data

Shook Hardy & Bacon LLP
-
European Union
-
May 16 2013

According to a news source, European Medicines Agency (EMA) Director Guido Rasi intends to appeal interim rulings recently issued by the European

National case law

Cuatrecasas Gonçalves Pereira
-
European Union, Portugal
-
May 9 2013

Reference for a preliminary ruling from the Landgericht Hamburg (Germany) on the Novartis Pharma GmbH v Apozyt GmbH proceedings, pursuant to article

IP challenges for the personalised medicines industry - gene claims (part 1)

Barker Brettell LLP
-
European Union, United Kingdom, USA
-
May 9 2013

When you go to the doctor you expect to be asked a lot of questions about your symptoms and your lifestyle, as the doctor builds up a clinical

Interim relief granted in challenge to EMA's decision to disclose pre-clinical and clinical information from an application for a centralised marketing authorisation

Arnold & Porter LLP
-
European Union
-
May 7 2013

InterMune UK Ltd and its associated companies have challenged a decision of the European Medicines Agency (EMA) to disclose to a third party

next >

Search results

US and European approaches to antibody patents

Pharmaceutical trade marks case law round up for 2012early 2013

Interim measures awarded against European medicines agency

Stem cell news - EPO revokes ‘Brüstle’ patent and new CJEU referral on the patentability of parthenotes

CJEU C-53511 marketing authorizations are not under certain conditions necessary for the repackaging of medicinal products

UK: Court of Appeal refers questions on parallel imports to CJEU

EU Medicines Agency plans to appeal interim rulings on release of clinical trial data

National case law

IP challenges for the personalised medicines industry - gene claims (part 1)

Interim relief granted in challenge to EMA's decision to disclose pre-clinical and clinical information from an application for a centralised marketing authorisation

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea